Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 29:14:20420188231207345.
doi: 10.1177/20420188231207345. eCollection 2023.

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

Li-Hsin Chang  1 , Chia-Huei Chu  2   3 , Chin-Chou Huang  4 , Liang-Yu Lin  5   6
Affiliations

Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus

Li-Hsin Chang et al. Ther Adv Endocrinol Metab. .

Abstract

Background: Inflammations are the crucial pathogenesis of chronic complications of type 2 diabetes mellitus (T2DM).

Objectives: The timeline of cardiovascular and renal complications of T2DM and whether soluble tumor necrosis factor receptor type 1 (sTNFR1) levels predict cardiorenal outcomes were still elusive.

Design: Prospectively observational study.

Methods: Chinese patients with T2DM were enrolled. Cardiorenal composite events defined by either cardiovascular composite events (all-cause mortality, acute coronary syndrome, or non-fatal stroke) or renal composite events (a decline of >30% of renal function or worsening status of albuminuria) were followed. Associations of sTNFR1 levels and cardiovascular, renal, and cardiorenal composite events were analyzed in regression models presented by hazard ratio (HR) and 95% confidence interval (95% CI).

Results: Among 370 subjects, 42 cardiovascular and 86 renal composite events occurred. Higher sTNFR1 levels were related to higher frequency and risks of cardiovascular composite events (HR 1.07, 95% CI 1.01-1.13, p = 0.009) and renal composite events (HR 1.05, 95% CI 1.02-1.09, p < 0.001). Occurrences of cardiovascular composite events were not predicted by precedential renal composite events. sTNFR1 levels were proved to be associated with risks of cardiorenal composite events in Cox regression sequential models (adjusted HR 1.04, 95% CI 1.00-1.08, p = 0.03). The results were consistent in all subgroup analyses.

Conclusion: Levels of sTNFR1 were associated with cardiorenal complications of T2DM and the predictabilities of TNFR1 levels were better than precedential cardiovascular or renal events.

Keywords: macrovascular complications; microvascular complications; soluble tumor necrosis factor receptor type 1; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Patient disposition.
Figure 2.
Figure 2.
Kaplan–Meier curve showing the probability of cumulative events-free survival of cardiovascular (a), renal (b), and cardiorenal composite events (c) in patients with type 2 diabetes mellitus divided into groups based on concentration tertiles of sTNFR1. sTNFR1, soluble tumor necrosis factor receptor type 1.
See this image and copyright information in PMC

References

    1. Cho NH, Shaw JE, Karuranga S, et al.. IDF Diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271–281. - PubMed
    1. Leasher JL, Bourne RR, Flaxman SR, et al.. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 2016; 39: 1643–1649. - PubMed
    1. Cheng HT, Xu X, Lim PS, et al.. Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015. Diabetes Care 2021; 44: 89–97. - PubMed
    1. Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, et al.. Association of cardiometabolic multimorbidity with mortality. JAMA 2015; 314: 52–60. - PMC - PubMed
    1. Gregg EW, Cheng YJ, Srinivasan M, et al.. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 2018; 391: 2430–2440. - PubMed

LinkOut - more resources